Kim Eng Securities (Hong Kong) was established in 1988 and Kim Eng Futures in 1992. We have provided equities research to institutional clients since 1990, while our retail business franchise was officially set up in 2010. Post-merger, collaboration with other Maybank Kim Eng offices in the region has increased. Notably, the Equities team now has access to regional resources and support.
In 2012, we launched the futures and options online trading platform with the purpose of offering more trading channels to clients, while the Regional Online Trading Platform was launched in December. We were also able to build our investment banking unit within a short period of time.
On the investment banking front, in 2012, we were the Joint Bookrunner and Joint Lead Manager for the HKD1.325 billion Xiwang Special Steel IPO. In 2013, we successfully led the USD90 million spin-off IPO for Beijing Tong Ren Tang Chinese Medicine, which was one of the best performing IPOs to debut in Hong Kong that year. We have also acted as Co-Advisors to a private equity consortium led by Citic Capital on the USD890 million privatisation of Nasdaq-listed Asiainfo-Linkage. Our other achievements for 2013 also included being a Joint Sponsor for Tonly Electronics’s spin-off and China Saite’s USD53 million IPO. In 2014, we continued to build on our momentum and led the USD36 million IPO for Broad Greenstate.
Kim Eng Securities (Hong Kong) is a trusted broker, having been named Best ASEAN Broker at the Hong Kong Most Valuable Companies Awards. At the individual level, our analysts have consistently done well at the StarMine Analyst Awards, featuring among the Top 3 Analysts for both the Food & Beverage and Real Estate & Construction sectors in 2013.
- Hong Kong Securities
- Warrants & CBBCs
- Margin Financing
- Foreign Stocks
- Futures and Options
- Global Futures
- KE Trade
- Investment Immigration Services
- KE CFD